Sunday, February 11, 2018

Recent Sell & Buy – January – TEVA, Ventas, Gilead Sciences

I bought a few shares of TEVA in August 2017. I thought that the market overreacted the announced goodwill impairment, and it has a good valuation. As I saw the revenue and EPS decline, and the large restructuring, I felt that I can not predict the profit of the company for the next few years and I closed my long position at $21.41. It brings me a small profit for this few months.



(Source: www.finviz.com)

I bought Ventas (VTR) shares at $56.19 which means 5.52% dividend yield for me. I think that VTR is a great company, which increased it's dividend in the last 7 years and has not decreased it in 2008-2009.


(Source: www.finviz.com)


As I have more money after selling my TEVA shares, I bought a few shares of Gilead Sciences (GILD) at $80.74 which gives me 2.86% dividend yield (after the recently announced dividend increase).


  (Source: www.finviz.com)



Full disclosure: Long VTR, GILD

Related Posts:

No comments:

Post a Comment